pretickt

VRTX peers and competitors

Vertex Pharmaceuticals Incorporated · end-of-day data as of Oct 16, 2026

Vertex Pharmaceuticals Incorporated
VRTX · $127B
$499.74+4.7%last 60 sessions · close Oct 16, 2026
$408.61$557.9652 weeks
Buy · 33 analystsPT $569.95 +14.0%
  • P/E vs own+3.3%
  • P/E vs sector+3.3%
  • Target upside+14.0%
  • Off 52w high-10.4%
  • InsidersNone in 90d
  • FCF yield+3.0%
  • Earnings in17d
  • Trendbullish
  • Sector▲ +16.0%
  • RSI44
  • MA20×50Death 9d ago
  • Volume1.2x
  • Support-1.1%
  • Resistance+2.4%

VRTX’s peers by industry and size include Intuitive Surgical (ISRG), Bristol-Myers Squibb (BMY) and Medtronic Plc (MDT). Among these 12 companies VRTX ranks 2nd by market cap ($127B); its P/E of 29.1 compares with a median of 25.7 for its peers.

Peers by industry and size

20D
1ISRGIntuitive Surgical, Inc.$426.70-0.3%-28.0%+12.1%48.5$151B
2VRTXVertex Pharmaceuticals Incorporated$499.74-1.8%-10.4%+14.0%29.1$127B
3BMYBristol-Myers Squibb Company$59.75-1.4%-11.3%+9.4%13.2$122B
4MDTMedtronic Plc$94.75-0.7%-7.1%+4.0%23.3$121B
5CVSCVS Health Corp.$92.36-0.2%-16.0%+20.9%24.4$118B
6MCKMcKesson Corporation$1,004.84+0.6%0.0%-1.5%26.9$117B
7SYKStryker Corporation$294.66+0.5%-23.3%+23.9%30.5$113B
8MRNAModerna, Inc.$218.01-7.8%-7.8%-25.0%—$87.04B
9REGNRegeneron Pharmaceuticals, Inc.$790.74-0.7%-7.2%+8.7%19.6$81.41B
10ALNYAlnylam Pharmaceuticals, Inc.$231.83-0.9%-52.8%+61.5%39.2$31.02B
11INCYIncyte Corporation$113.07-0.2%-13.0%+13.6%14.4$22.92B
12TECHBio-Techne Corporation$72.57+0.1%-0.1%-7.0%62.6$11.38B

Data as of Oct 16, 2026 close.